The investment team at Woodford Investment Management believe there are 'encouraging' signs of a reversal in the factors that contributed to the underperformance of the £8.9bn UK Equity Income fund in the first half of the year.
The fund's performance was hit over the summer by sharp share price falls for key holdings such as Provident Financial and AstraZeneca, which fell 70% and 16% in a day, respectively. This caused the Equity Income fund to underperform, while some investors, including Jupiter's Merlin team, chose to withdraw their holdings, sending assets under management down to £8.9bn in September from a peak above £10bn in June. Over the three months to 19 October, the fund has lost 4% versus positive returns of 3.1% by the IA UK Equity Income sector, according to FE. Woodford: I'm very sorry for ...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes